ライフサイエンスコーパス: H3N2 influenza virus

1 mperature very similar to that of a seasonal H3N2 influenza virus.

2 ith similar efficiency to that of a seasonal H3N2 influenza virus.

3 dy weight loss and death upon infection with H3N2 influenza virus.

4 ontact and airborne transmission of H1N1 and H3N2 influenza viruses.

5 y between genetic and antigenic evolution of H3N2 influenza viruses.

6 er titers compared with five common seasonal H3N2 influenza viruses.

7 oad cross-reactivity against H1N1 as well as H3N2 influenza viruses.

8 ssion between the pandemic H1N1 and seasonal H3N2 influenza viruses.

9 additional glycosylation on the virulence of H3N2 influenza viruses.

10 lded 21 novel (H1N1) viruses and 2 seasonal (H3N2) influenza viruses.

11 The first pandemic season of A/H3N2 influenza virus (1968/1969) resulted in significant

12 , but it was the second pandemic season of A/H3N2 influenza virus (1969/1970) that caused the majorit

13 (influenza virus A-1), 40 influenza virus A H3N2 (influenza virus A-3), 37 influenza virus A "equivo

14 monocytes could be readily infected with the H3N2 influenza virus A/Udorn/72 (Udorn), irrespective of

15 ent was unique because the causative agents, H3N2 influenza viruses, are infrequently isolated from s

16 (SK06, H5N1) and A/Tokyo/Ut-Sk-1/07 (Tok07, H3N2) influenza viruses by reverse genetics.

17 y in elderly subjects, suggesting that older H3N2 influenza viruses confer some cross-reactive antibo

18 Circulating A/H3N2 influenza viruses drifted significantly after strai

19 nactivated A/Aichi/68 (H3N2) or A/Sydney/97 (H3N2) influenza virus elicited complete protection again

20 The RAMM model calibrated to historical H3N2 influenza virus evolution in humans fit well to the

21 Novel H3N2 influenza viruses (H3N2v) containing seven genome s

22 The SA binding properties of H3N2 influenza viruses have been observed to change duri

23 stances) caused an antigenic drift event for H3N2 influenza viruses historically.

24 on to TMPRSS2, is able to activate the HA of H3N2 influenza virus in vivo IMPORTANCE: Influenza epide

25 Isolation of human subtype H3N2 influenza viruses in embryonated chicken eggs yield

26 ency of severe infections seen with seasonal H3N2 influenza viruses in recent decades compared to the

27 r that is involved in cleavage activation of H3N2 influenza viruses in vivo.

28 al antibody for the therapeutic treatment of H3N2 influenza virus infection.

29 the mice were comparably susceptible to X31 (H3N2) influenza virus infection.

30 that the aerosol transmission of a seasonal H3N2 influenza virus is most efficient under cold, dry c

31 his report we describe a multidrug-resistant H3N2 influenza virus isolated from an immunocompromised

32 Here, NK lysis of cells infected with human H3N2 influenza viruses isolated between 1969 and 2003 wa

33 ected antigenic variants from human H1N1 and H3N2 influenza virus libraries possessing random mutatio

34 r infection of Tmprss2 knockout mice with an H3N2 influenza virus, only a slight increase in survival

35 d then determined the role of that domain in H3N2 influenza virus pathogenicity.

36 recovery from infection caused by a shifted (H3N2) influenza virus, probably through the induction of

37 e PB1-F2 reading frame in a recent, seasonal H3N2 influenza virus strain did not affect these paramet

38 Animals previously infected with an H3N2 influenza virus succumbed to systemic disease and e

39 component of recent antigenic drift in human H3N2 influenza viruses, supporting the idea that influen

40 acts of ferrets infected with H5N1, H1N1, or H3N2 influenza viruses that exhibit diverse virulence an

41 Here, we evaluated whether prior seasonal H3N2 influenza virus vaccination or infection affects vi

42 ") were inoculated with A/Wisconsin/67/2005 (H3N2) influenza virus via intranasal drops.

43 ever, we recently found that a human-lineage H3N2 influenza virus was highly restricted in its abilit

44 currently cocirculating avian H5N1 and human H3N2 influenza viruses, we generated all the 254 combina

45 providing long-term cross-protection against H3N2 influenza virus when compared to other vaccination

46 10 different genotypes of novel reassortant H3N2 influenza viruses with 2009 pandemic H1N1 [A(H1N1)p

47 We showed that reassortant H3N2 influenza viruses with 3 or 5 genes from A(H1N1)pdm